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Background and aims: Platelet rich plasma (PRP) obtained from blood anticoagulated
with acid-citrate-dextrose (ACD) or sodium-citrate (SC) is used for regenerative medicine
as source of platelet-derived growth factors. Allergic reactions against citrate were
reported in patients after local injection of PRP allowing us to hypothesize that
anticoagulants exert a harmful and local effect that interferes with the regenerative
proprieties of platelets. Herein we test this hypothesis by analyzing the effect of ACD
and SC on angiogenic and regenerative responses mediated by platelets.
Methods: PRP was obtained from SC- or ACD-anticoagulated blood; platelets were
lysed to release growth factors; and PRP releasates (PRPr) were used to induce in vitro
endothelial proliferation and 2D-migration, and regeneration of mouse skin wounds.
Results: We first compared proliferation and migration of endothelial cells mediated by
anticoagulated-PRPr supplemented or not with CaCl2. Alteration of endothelial adhesion
and impediment of proliferation and migration was observed without CaCl2. Although
endothelial morphology was normalized in SC- and ACD-PRPr after calcium restitution,
angiogenic responses were only markedly induced by SC-PRPr. In vivo studies revealed
a delay in mouse skin regeneration after treatment with anticoagulated-PRPr without
CaCl2. Healing was only induced after calcium restitution in SC- but ACD-PRPr.
Moreover, the development of inflammatory intradermal papules was evidenced after
injection of ACD-PRPr. Supplementation of SC-PRPr with the equivalent concentration
of dextrose (D-Glucose, 18 mM) present in ACD-PRPr resulted in reduction of endothelial
proliferation and migration, delay of mouse skin regeneration and development of
intradermal papules. Finally, collecting blood with half amount of SC significantly
improved all the angiogenic and regenerative responses mediated by PRPr. In contrast,
the delay of skin regeneration and the development of inflammatory papules remained
stable after dilution of ACD.
Conclusion: Our findings indicate that (1) calcium restitution is required to impair the
cellular and tissue alterations induced by citrated-anticoagulants contained in PRP; (2)
ACD-derived dextrose confers anti-angiogenic, anti-regenerative and pro-inflammatory
proprieties to PRP; and (3) half concentration of SC improves the angiogenesis and
regeneration mediated by PRP.
Keywords: acid-citrate-dextrose, angiogenesis, anticoagulants, glucose, platelet-rich-plasma, trisodium-citrate,
regeneration
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INTRODUCTION
Besides playing a key role in thrombosis and hemostasis platelets
also promote tissue regeneration due to the action of several
growth factors and cytokines released from their granules.
For this reason, platelet-rich plasma (PRP) based therapies
are used in regenerative medicine for treating several clinical
conditions including ulcers, burns, muscle damage, bone diseases
and in tissue recovery after surgery (Etulain, 2018; Anitua
et al., 2019). Despite the large variability of applications, the
efficacy of regenerative treatments using PRP has been called
into question due to the absence of large controlled clinical
trials and consensus regarding PRP preparation techniques.
The procedures currently used for this purpose are derived
from classical protocols for obtaining platelet concentrates for
transfusion, coagulation assays or platelet functionality, which
are focused on preserving platelet hemostatic responses (Etulain
et al., 2018). Most of these protocols use citrate as a common
element in anticoagulant-conservative solutions. Citrate-based
anticoagulants prevent coagulation by their ability to chelate
ionized calcium present in the blood to form non-ionized
calcium-citrate complexes (Mariano et al., 2011). This allows
to preserved the hemostatic functionality of platelets for long
periods of time (5–7 days) and it is also safe and efficient
for transfusions since citrate is diluted in volemia and rapidly
metabolized to bicarbonate by the tricarboxylic pathway in
liver, kidney, and skeletal muscle (Leparc, 1985; Mariano et al.,
2011). Based on these classical settings, acid-citrate-dextrose
(ACD) and sodium citrate (SC) solutions are commonly used
for collecting blood in the context of regenerative protocols
mediated by platelets (The International Cellular Medical Society,
2012; Dhurat and Sukesh, 2014; Anitua et al., 2016). The studies
about the effect of anticoagulants in the context of regenerative
treatments with platelets are only focused on optimizing platelets
number, coagulation or platelet-derived growth factors levels
(O’Neill et al., 2001; Giraldo et al., 2015; do Amaral et al.,
2016; Gonzalez et al., 2016; Singh, 2018) but they do not
analyze the functionality of platelets on target tissue neither
the possible adverse consequences caused by anticoagulants
additives in platelet solutions. Notably, adverse effects have
been reported in patients in the context of tendinopathies
treatments with PRP including swelling, erythema, edema, and
pain (Bowman et al., 2013; Kaux et al., 2014); skin redness,
swelling, bruising, pruritus, scaling, and dryness after intra-
dermal injection of PRP in the context of skin rejuvenation
(Alam et al., 2018); and the systemic allergic reaction post-
injection of PRP into a bone cyst (Latalski et al., 2019).
Although the potential mediators/mechanisms involved in these
effects were not addressed, one of these studies revealed
the intradermal allergic reaction against citrate during skin
allergic test (Latalski et al., 2019) suggesting a possible toxic
effect caused by the anticoagulant additive in PRP. To further
understand the local effect of citrate on tissue regeneration
we evaluated the effect of ACD and SC analyzing their effect




Human blood studies were conducted according with the
Declaration of Helsinki and the Ethic Committee of the National
Academy of Medicine (T.I. 12910/18/X). All subjects provided
informed written consent for the collection of samples and
subsequent analysis.
Animal studies received the approval of the Institutional
Committee for Care and Use of Laboratory Animals (CICUAL
059/2018) and were conducted according to principles set forth
in the Guide for the Care and Use of Laboratory Animals (8th
Ed. NRC, United States) and by the European Parliament and
Council concerning the protection of animals used for scientific
purposes (Directive 2010/63/EU).
Preparation of PRP Releasates (PRPr)
Blood samples were obtained by venous puncture from healthy
donors that assist to the Hemotherapy Service of Hospital
Fernández (CABA, Argentina), and who had not taken non-
steroidal anti-inflammatory drugs during the 10 days before
sampling. Blood was collected in tubes containing trisodium
citrate (SC) 3.8% (1:9 v/v) or ACD (Formula A solution,
trisodium citrate 22.0 g/L, citric acid 7.3 g/L, and dextrose
21.8 g/L, 1.5:8.5 v/v).
Blood samples were store at room temperature for a maximum
of 40 min before PRP preparation. Blood was centrifuged at
180 × g for 10 min to obtain PRP and platelets were lysed
by two cycles of freezing and thawing (−80◦C, 15 min). After
PRP separation, remaining blood was centrifuged at 890 × g for
10 min to obtain platelet poor plasma (PPP). Then, coagulation
in lysed PRP and PPP was induced by adding CaCl2 (22–25 mM).
After 40 min of incubation at 37◦C, clot was removed and the
PRP releasates (PRPr) and PPP were centrifuged at 890 × g for
10 min and then stored at−80◦C until used.
In vitro Endothelial Proliferation and
2D-Migration Assays
Human microvascular endothelial cells (HMEC-1) were grown in
MCDB-131 supplemented with fetal bovine serum (FBS) (10%),
L-glutamine (10 mM) and streptomycin (100 µg/mL), penicillin
(100 U/mL), EGF (10 ng/mL), and hydrocortisone (1 µg/mL) at
37◦C in a humidified 5% CO2 incubator (Etulain et al., 2018).
Human umbilical vein endothelial cells (HUVEC) were obtained
from four different donors as previously described (Mena et al.,
2018) and were expanded and maintained in Endothelial Growth
Medium 2 (EGM2; Lonza, Walkersville, MD, United States)
containing Endothelial Basal Medium 2 (EBM2) supplemented
with FBS, hydrocortisone, human fibroblast growth factor
(hFGF), VEGF, human long R3, insulin-like growth factor-
1 (R3-IGF-1), ascorbic acid, human epidermal growth factor
(hEGF), gentamicin, amphotericin-B and heparin (Mena et al.,
2014). After washing, growth factor-enriched medium was
totally replaced by PRPr. The proliferation of endothelial cells
(15 × 103, indicated as dotted line in Figures) was determined
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at 24 h by measuring acid phosphatase activity and confirmed
by Neubauer chamber cell counting. Migration into scratched
confluent monolayers of endothelial cells was analyzed at 8 h
with ImageJ software and the percentage of migration was
calculated as [(wound area at 0 h - wound area at 8 h)/wound
area at 0 h] × 100 (Etulain et al., 2013, 2018). Evaluation of
endothelial viability was analyzed under optical microscopy by
trypan blue exclusion test.
Growth Factors Determination
Levels of VEGF (RayBiotech, Inc., Norcross, GA, United States),
bFGF (Biolegend, San Diego, CA, United States), EGF
(Life Technologies, Carlsbad, CA, United States), PDGF
(Abcam, Cambridge, United Kingdom), and TGFβ
(Biolegend, San Diego, CA, United States) in PRPr were
determined by ELISA.
Mice
Female BALB/c mice, 8–10 weeks old, originally purchased
from Charles River Research Animal Diagnostic Services
(Wilmington, MA, United States) were housed in a controlled
environment with free access to water and a standard diet in
the animal facility of the Institute of Experimental Medicine
(Etulain et al., 2018).
Model of Wound Healing in Mice
Platelet rich plasma was obtained from orbital blood of
anesthetized mice and collected in SC or ACD. Platelets were
lysed at −80◦C during 15 min, and releasates were obtained
after centrifugation. PRPr were supplemented or not with
CaCl2 immediately before being injected subcutaneously in
the periphery of four round full-thickness excisional wounds
of 3 mm diameter generated in the back skin of other
anesthetized mice (Etulain et al., 2018). Saline (0.9 g NaCl/100 ml
distilled water) was used as control. Wound healing was
analyzed at 3 and 6 days post-injury. Back skin of mice
was photographed and the perimeter of the wound area was
calculated using the ImageJ software. Results were expressed
as a percentage of the area at day 0 when wounds were
excised. The presence of intradermal infiltrates (papules) in
the periphery of wounds was quantified macroscopically.
Anesthetized mice were culled, and paraffin sections of skin
wounds were stained with Masson’s trichrome. Images were
captured using an inverted microscope and analyzed using the
ImageJ software.
Statistical Analysis
Results are expressed as means ± SEM. A P < 0.05 was
considered statistically significant. The Shapiro-Wilk test was
used to define state normality and equal variance. In case of
sample normality and equal variance, parametric tests such us
one- or two-way analysis of variance (ANOVA) followed by
Fisher’s test were used. If normality assumption failed, non-
parametric such us Kruskal Wallis follows by Dunns or Mann-
Whitney tests were performed. All the tests were used according
to the experimental design and analyzed with GraphPad software
(PRISM Version 8.0, San Diego, CA, United States).
RESULTS
The Reduction of Calcium Levels
Exerted by Anticoagulants Interferes
With Endothelial Proliferation and
Migration Mediated by PRPr in vitro
Considering that calcium is a second messenger essential for the
cellular homeostasis (Dubois et al., 2016; Bootman et al., 2018) we
first evaluated whether anticoagulants interferes with angiogenic
responses mediated by platelets by chelating calcium. To this
purpose, PRP was obtained from blood samples anticoagulated
with either SC or ACD; platelets were lysed; coagulation was
activated or not by CaCl2 addition and supernatants (containing
the platelet releasates, PRPr) were used as inducers of HMEC-
1 proliferation and migration, both responses required during
angiogenesis. Platelet poor plasma (PPP) was used as control.
In contrast with the isolated and attached morphology of
cells observed before treatments, incubation of HMEC-1 for
24 h with PPP or PRPr without addition of CaCl2 resulted in
the aggrupation of cells in clusters and no cell proliferation
(Figure 1A). Normal cobblestone endothelial cell morphology
was observed by treatment of HMEC-1 after calcium restitution
confirming the crucial role of this cation in cellular adhesion
and morphology. Moreover, cell proliferation from the original
number of 15 × 103cells (dotted line) was triggered by PRPr,
being that induced by SC-PRPr higher than ACD- (Figure 1A).
Similar to the proliferation results, cell migration was not
observed in cells exposed to PPP although the angiogenic
response was triggered by SC-PRPr but not ACD- (Figure 1B).
Moreover, alteration of cellular morphology evidenced as
disruption and density changes of confluent monolayer limiting
wounds was observed after experimental conditions without
CaCl2. Analysis of cellular viability showed that 15 and 20%
of HMEC-1 death was detected after 24 h of incubation with
SC-PRPr and ACD- without CaCl2, respectively (Table 1).
Levels of cellular death were reduced after restitution of CaCl2
without showing significant differences between SC-PRPr and
ACD- treatments (Table 1). These results suggest that decrease
of angiogenic responses observed in non-calcium conditions
could be partially explained by endothelial death. In contrast,
differences in cell proliferation and migration between SC-PRPr
and ACD- were not associated to a differential induction of
cellular death (Table 1) neither to a differential recovery in
platelet number or levels of growth factors on PRPr (VEGF,
PDGF, EGF, bFGF, and TGFβ) (Table 2). To rule out that
results were associated with the use of an immortalized cell
line, the experiments were repeated using a primary cell culture
of HUVEC. Proliferation and migration of endothelial cells
was again only induced after calcium restitution, being that
induced by SC-PRPr higher than ACD- (Figures 1C,D). Similar
results were also observed in the treatments containing a
commercial growth factors-enriched medium (EGM2) instead
PRPr indicating that the effect exerted by anticoagulants is
extended to different types of endothelial cells and culture media.
In addition, a similar pattern-effect exerted by anticoagulants was
observed on HMEC-1 and HUVEC viability. Specifically, while
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FIGURE 1 | The effect of calcium restitution and citrate-anticoagulants in endothelial proliferation and migration mediated by PRPr. (A,B) Platelets contained in
SC-PRP and ACD- were lysed to release total amount of platelet-derived growth factors and then coagulated or not with CaCl2. Clot was removed and PRPr
releasates (PRPr) were incubated with HMEC-1. SC-PPP and ACD- coagulated or not with CaCl2 were used as control. Endothelial cell proliferation at 24 h (A) and
migration at 8 h (B) were determined. Images are representative of seven independent experiments and were obtained before and after treatments (magnification
40X). (C–D) HUVEC were incubated with SC-PRPr and ACD- supplemented or not with CaCl2. SC-EGM2 or ACD- supplemented or not with CaCl2 was used as
control. Endothelial proliferation at 24 h (C) and migration at 8 h (D) were determined (n = 4–7; *P < 0.05, **P < 0.01, ***P < 0.001 vs. CaCl2 (-); #P < 0.05,
##P < 0.01 vs. SC-PRPr or SC-EGM2. Two-way ANOVA followed by Fisher test).
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TABLE 1 | HMEC-1 and HUVEC viability.
Cellular viability
after 24 h of PRPr
(%)
HMEC-1 HUVEC
-CaCl2 +CaCl2 −CaCl2 +CaCl2
PRPr-SC 85 ± 8 97 ± 6* 78 ± 8 93 ± 7*
PRPr-ACD 80 ± 7 89 ± 6* 72 ± 8 86 ± 7*
PRPr-
SC + Glucose
– 91 ± 8 – 90 ± 8
PRPr-1/2SC – 97 ± 6 – 94 ± 6
PRPr-1/2ACD – 95 ± 7 – 91 ± 8
n = 4, *P < 0.05 vs. -CaCl2
TABLE 2 | Hematology parameters and growth factors levels.
SC ACD 1/2SC 1/2ACD
Whole Blood (WB)
WBC (×109/L) 7.6 ± 0.6 7.7 ± 0.7 7.5 ± 0.5 7.8 ± 0.7
RBC (×1012/L) 4.6 ± 0.2 4.5 ± 0.3 4.8 ± 0.3 4.8 ± 0.2
Plt (×109/L) 243 ± 48 227 ± 32 262 ± 47 239 ± 41
Platelet Rich Plasma (PRP)
WBC (×109/L) 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
RBC (×1012/L) 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Plt (×109/L) 435 ± 68 502 ± 106 490 ± 84 451 ± 78
Plt (fold of WB) 2 2 2 2
Plt (% recovery) 62 ± 5 63 ± 10 66 ± 8 63 ± 10
pH 7.5 ± 0.6 7.4 ± 0.6 7.6 ± 0.7 7.6 ± 0.8
Levels of Growth Factors in lysed PRP releasates (PRPr)
VEGF (pg/ml) 11750 ± 958 10900 ± 656 12417 ± 740 11233 ± 525
PDGF (pg/ml) 29061 ± 1985 27608 ± 1924 33222 ± 1685 32445 ± 1598
EGF (pg/ml) 277 ± 42 272 ± 35 306 ± 39 310 ± 58
bFGF (pg/ml) 353 ± 22 380 ± 15 368 ± 30 366 ± 26
TGFβ (pg/ml) 2008 ± 198 2063 ± 175 1866 ± 162 2032 ± 178
Blood and PRP samples were examined using a hematology analyzer (Abacus
Junior R©). The percentage of platelet recovery was calculated as (Platelet
concentration in PRP × volume PRP/Platelet concentration in WB × volume
WB) × 100. Levels of growth factors in releasates of lysed PRP (PRPr) were
determined by ELISA.
22–28% of HUVEC death was found after 24 h of incubation
with non-calcium treatments, cellular viability was significantly
increase after CaCl2 addition (Table 1). After restitution of
calcium, not significant differences on viability were observed
between SC-PRPr and -ACD. Therefore, and similar with
proliferation and migration findings, the effect of anticoagulants
is extended to different types of endothelial cells.
ACD but Not SC Induces Inflammation
and Impairs PRPr-Mediated
Regeneration in vivo
To study the relevance of the in vitro findings we next analyzed
the effect of citrate-anticoagulants in a model of skin regeneration
in vivo (Etulain et al., 2018). For these experiments, PRP was
obtained from murine blood collected with SC or ACD. After
lysis of platelets, coagulation was activated or not with CaCl2
and the four different treatments (1:SC; 2:SC + CaCl2; 3:ACD;
4:ACD + CaCl2) were subcutaneously injected in the periphery
of four round full-thickness excisional wounds generated in the
back skin of other mice. Wound healing was monitored at 3
and 6 days post-injury. Our findings indicate that the kinetic of
macroscopic healing mediated by SC-PRPr was accelerated by
restitution of calcium levels. Specifically, while wound closure
was not modified after 3 days by PRPr-SC without calcium,
31 ± 6% closure was reached in the presence of calcium
(Figure 2A). These differences were also evidenced at day 6
reaching 57 ± 6% of wound closure by PRPr-SC + CaCl2,
significantly higher than the 25 ± 3 and 22 ± 2% induced by
PRPr-SC (-CaCl2) or saline, respectively. On the other hand,
wound perimeter was increased after 3 days of treatment with
ACD-PRPr (-CaCl2) resulting in a negative value in the wound
closure% and suggesting that tissue damage was induced by this
experimental condition. Similar results were observed when ACD
was injected with saline instead of PRPr (Supplementary Figure
1) indicating that ACD injection exerts a direct harmful effect
on mouse skin. Even when the harmful effect of ACD was not
observed when calcium was restored, the wound closure after
6 days of ACD-PRPr did not exceed the physiologic wound
closure of the saline control group (Figure 2A, dotted line)
indicating that the regenerative capacities of PRP are inhibited
by ACD regardless the presence of calcium.
To further understand the effect of anticoagulants on the
regenerative properties of PRP, the histological examination of
skin biopsies stained with Masson’s trichrome was performed
on day 6 (Figure 2B). Three different histological criteria were
used to evaluate wound healing: (1) epidermal regeneration
quantified as a reduction in hyperplastic neoepidermis thickness
(Figure 2C); (2) granulation tissue development as a provisional
matrix for regeneration (Figure 2D); and (3) regeneration
of skin mature annex structures, including sebaceous glands
(SG) and hair follicles (HF) (Figure 2E; Etulain et al., 2018).
Images obtained in the center of wounds revealed that after
6 days of treatment with SC-PRPr (without calcium) the
neoepidermis remained thick and hyperplastic due to the
presence of stratum corneum (red) and a thick papillary
dermis (adjacent below stratum corneum) (Figures 2B,C).
Development of large granulation tissue (dotted line) constituted
by fibroblasts and dermal matrix collagen (blue) was also
evidenced under these conditions (Figures 2B,D). Similar results
were obtained with saline controls (Supplementary Figure 1)
indicating that regeneration was not accelerated in this PRPr
condition. In contrast, a significant reduction in epidermal
thickness and granulation tissue volume together with the
incipient regeneration of annex structures was observed after
SC-PRPr + CaCl2 treatment (Figures 2B–E). Regarding ACD, a
delay on granulation tissue formation was observed in wounds
treated with ACD-PRPr –CaCl2. Although it was normalized
after calcium restitution, this treatment was not able to induce
peripheral dermal regeneration as it was induced by the
equivalent condition obtained with SC.
Together with the analysis performed in the center of wounds,
the presence of dermal inflammatory infiltrates (papules)
containing leukocytes was evidenced in the periphery of wounds
treated with PRPr containing ACD ± CaCl2 (Figure 2F). This
phenomenon was not associated with the presence of leukocytes
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 5 March 2020 | Volume 8 | Article 223
fbioe-08-00223 March 18, 2020 Time: 16:51 # 6
Oneto et al. Anticoagulants and Platelet-Mediated Regeneration
FIGURE 2 | ACD but not SC induces inflammation and impairs PRPr-mediated mouse skin regeneration. Four round full-thickness excisional wounds of 3 mm in
diameter were generated in the back skin of female BALB/c mice (8–10 weeks old). SC-PRPr or ACD- obtained from other mice were supplemented or not with
CaCl2 and injected subcutaneously in the periphery of wounds. Saline was used as control. Healing was analyzed at 3 and 6 days post-injury. (A) Wounds were
photographed and wound closure% was determined by quantification of wounds perimeters using the ImageJ software. (n = 14; &P < 0.05, &&P < 0.01 vs. saline;
*P < 0.05; **P < 0.01 vs. CaCl2 (-); ##P < 0.01 vs. SC-PRPr. Repeated Measures One-way ANOVA followed by Fisher test). (B) Skin biopsies obtained on day 6
were stained with Masson’s trichrome. Images of the center of wounds were captured using an inverted microscope. (C) Epidermal thickness, (D) granulation tissue
volume (dotted lines), and (E) annex structures (hair follicles and sebaceous glands) were quantified using the ImageJ software. (F) Images of the periphery of
wounds were captured and intradermal inflammatory infiltrates were quantified. SG, sebaceous gland; HF, hair follicle; E, epidermis; D, dermis; F, fat layer; M, muscle
layer. (Magnification 100X). (n = 14; *P < 0.05; **P < 0.01 vs. CaCl2 (-); #P < 0.05, ##P < 0.01 vs. SC-PRPr. Two-way ANOVA followed by Fisher test).
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in PRP (not shown). In addition, the inflammatory papules
were not observed in the periphery of wounds treated with
PRPr containing SC (Figure 2F) or ACD-Saline (Supplementary
Figure 1F). These results indicate that an adverse inflammatory
reaction is exerted by the combination of ACD and PRPr.
The D-Glucose (Dextrose) Is Responsible
for the Anti-Angiogenic,
Anti-Regenerative and Inflammatory
Effect Exerted by ACD
Having shown that the differences between SC and ACD were not
reversed after calcium restitution we wonder whether individual
components of ACD might be responsible for the angiogenic,
regenerative and inflammatory alterations. To evaluate the
differences between ACD and SC we focused on dextrose
(D-Glucose). For these experiments, SC-PRPr + CaCl2 was
supplemented or not with 18 mM of glucose as the equivalent
concentration of dextrose present in PRP that derives from
ACD; and it was used to induce angiogenic and regenerative
responses. As it is shown in Figure 3, while PRPr obtained
with SC was able to induce HMEC-1 and HUVEC proliferation
and migration, as well as in vivo wound closure and dermal
regeneration, all these responses were inhibited in the presence
of glucose (Figures 3A–D). The anti-angiogenic and anti-
regenerative effects of glucose were not be associated with an
increase in the death of endothelial cells since cellular viability
after incubation of HMEC-1 and HUVEC with SC-PRPr and
SC-PRPr + Glucose was similar (Table 1). Like the effects of
ACD-PRPr, the presence of inflammatory infiltrates was observed
in the periphery of wounds treated with SC-PRPr + Glucose.
In contrast, these papules were not detected in wounds treated
with saline controls supplemented or not with glucose indicated
that the observed inflammatory effect is exclusively due to the
combination of PRPr and glucose (Figure 3E).
Half Doses of Anticoagulants Increases
the Regenerative Capacity of PRP
A recent study showed that proliferation of fibroblasts induced
after supplementation of basal medium with 20% of PRP
increases when SC is reduced by half (Anitua et al., 2016).
In order to extend these results to our model, blood was
collected with total or half (1/2) concentrations of SC or
ACD. Our findings show that both proliferation and migration
were significantly increased by reduction of anticoagulant
concentration (Figures 4A,B). Angiogenic differences between
anticoagulant concentrations were not associated to differences
in the number of platelets recovered in PRP, neither in pH or
growth factor levels (Table 2). Regarding in vivo experiments, the
anti-regenerative and pro-inflammatory effect of ACD-PRPr was
slightly reduced and still present in the treatments containing half
ACD (Figures 4C–E). In contrast, a significant improvement on
the regenerative capacity of PRP was observed by reduction of
SC, reaching an 82 ± 7% of wound closure and almost complete
dermal regeneration after 6 days of treatment.
DISCUSSION
Although PRP is used as a source of platelet-derived growth
factors in regenerative medicine, its effectiveness remains
controversial partially due to the absence of PRP preparation
protocols based on the regenerative role of platelets (Etulain et al.,
2018). Instead, the current preparation methods are focused on
the hemostatic functions of platelets for transfusion purposes.
Unlike these protocols where platelets containing anticoagulants
are administered intravenously, during regenerative protocols
platelets (and their additives) are administered locally in
damaged tissues which are often not vascularized. Thus, it is
conceivable that the elimination of anticoagulant during these
local administrations differs from those described for systemic
administration. Our hypothesis is that anticoagulants exert a
harmful and local effect that interferes with the regenerative
proprieties of platelets. To test this hypothesis, we compared the
effect of SC and ACD on the overall angiogenic and regenerative
responses targeted by platelets.
Through in vitro studies we first demonstrated that the
calcium-chelating effect exerted by SC and ACD alters the
morphology of endothelial cells resulting in the inhibition of
endothelial proliferation and migration mediated by platelet
releasates. These results agree with the fundamental concepts
about the role of calcium-signaling pathways in cellular biology.
Calcium is a second messenger essential for the homeostasis of
all cellular and tissue processes and it triggers the activation
of several metabolic steps including cellular death (Moccia
et al., 2012; Dubois et al., 2016; Bootman et al., 2018; Paudel
et al., 2018). We also found that endothelial viability was
reduced in the absence of CaCl2 suggesting that decrease of
angiogenic responses observed in non-calcium conditions could
be partially explained by endothelial death. After restitution of
calcium, proliferation and migration of endothelial cells were
normalized when PRP was obtained with SC but not with
ACD. In these conditions, diminution on endothelial viability
by anticoagulated-PRPr or significant differences between
SC-PRPr and ACD- were not observed. Thus, differences
between treatments at physiologic levels of calcium would not
be explained by a cytotoxic effect of anticoagulants. Other
possibilities to explain this anti-angiogenic phenomenon could
be attributable to a cytostatic effect exerted by anticoagulants.
In addition, a metabolic effect of citrate independent of its
anticoagulant proprieties cannot be rule out. It could include
the alteration of intracellular pH, acid-based homeostasis and
intracellular citrate metabolism traditionally demonstrated in the
context of urine metabolism (Hamm, 1990).
Intriguingly, the anti-angiogenic effect of ACD has not been
reported in previous studies that evaluated proliferation of other
cells induced by PRPr in vitro (Lei et al., 2009; do Amaral et al.,
2016; Zhang et al., 2019). Of note, and in contrast with our
experimental settings where cells were incubated with medium
containing 100% of PRPr, the previous reports were performed
using complete culture medium supplemented with 1–20% of
PRPr suggesting that the effect of anticoagulants could have been
bypassed by dilution. Indeed, we have recently demonstrated that
the dilution of PRPr with saline between 25 and 50% increases
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FIGURE 3 | D-Glucose (Dextrose) confers anti-angiogenic, anti-regenerative and inflammatory proprieties to PRP. HMEC-1 (A) or HUVEC (B) were incubated with
SC-PRPr + CaCl2 (supplemented or not with Glucose 18 mM) or ACD-PRPr + CaCl2. MCDB-131 medium (A) or Endothelial Basal Medium 2 (EBM2) (B) both
supplemented with FBS 2% were used as control. Endothelial cell proliferation at 24 h and migration at 8 h were determined (n = 4; #P < 0.05 vs. SC-PRPr.
Kruskal-Wallis test followed by Dunn test). (C–E) Murine SC-PRPr + CaCl2 (supplemented or not with Glucose 18 mM) or ACD- were injected subcutaneously in the
periphery of wounds generated in back skin of other mice. Saline supplemented or not with Glucose was used as control. Healing was analyzed at 3 and 6 days
post-injury. (C) Wounds were photographed to determine the wound closure% (n = 8, &&P < 0.01 vs. saline; #P < 0.05, ##P < 0.01 vs. SC-PRPr. Repeated
Measures One-way ANOVA followed by Fisher test). (D) Skin biopsies obtained on day 6 were stained with Masson’s trichrome. Images of the center of wounds were
captured using an inverted microscope (Magnification 100X). (E) Number of intradermal inflammatory infiltrates in the periphery of wounds was quantified (n = 8).
the angiogenic and regenerative responses mediated by platelets.
This phenomenon was explained by the optimal balance reached
after dilution between pro- and anti-angiogenic factors derived
from platelets and plasma, respectively (Etulain et al., 2018). Now
we propose that another benefit of using diluted PRPr is the
consequent reduction of anticoagulants additive in the solution.
In agreement with the in vitro results, our in vivo findings
indicated both, that calcium supplementation is crucial to
restore the regenerative ability of anticoagulated-PRP and that
wound healing is delayed by ACD regardless the presence of
calcium. In addition, the presence of intradermal inflammatory
infiltrates was observed in the periphery of wounds treated
with ACD-PRPr. These anti-regenerative and pro-inflammatory
responses observed with ACD-PRPr were reproduced when
SC-PRPr was supplemented with glucose (18 mM) indicating
that glucose derived from ACD interferes with regeneration
mediated by platelets. Accordingly, and although normal levels
of glucose (5.5 mM) are essential for cellular metabolism, it
is well known that intermedia or high levels of this molecule
(10–30 mM) exert anti-angiogenic, inflammatory and cytotoxic
effects that contributes to the development of chronic wounds
in patients with diabetes (Shakya et al., 2015; Hu and Lan,
2016). Intriguingly, a delay in wound healing or the presence
of inflammatory papules were not observed in mice injected
with glucose alone (saline + glucose controls) indicating that
these phenomena are not induced by glucose alone but in
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FIGURE 4 | Reduction of SC and ACD concentrations improves the angiogenic and regenerative responses mediated by PRP. HMEC-1 (A) or HUVEC (B) were
incubated with PRPr obtained with total or half (1/2) concentration of SC or ACD. Endothelial cell proliferation at 24 h and migration at 8 h were determined (n = 4–5;
*P < 0.05, **P < 0.01 vs. total anticoagulant; #P < 0.05 vs. SC-PRPr. Two-way ANOVA followed by Fisher test). (C) Murine PRP was obtained with total or half (1/2)
concentration of SC or ACD. Platelets were lysed, coagulation was induced by CaCl2 and PRPr were obtained and injected subcutaneously in the periphery of
wounds generated in back skin of other mice. Saline was used as control. Healing was analyzed at 3 and 6 days post-injury. Wounds were photographed to
determine the wound closure% (n = 8. &P < 0.05, &&P < 0.01, &&&P < 0.001 vs. saline; **P < 0.01, ***P < 0.001 vs. total anticoagulant; ##P < 0.01, ###P < 0.001
vs. SC-PRPr. Repeated Measures One-way ANOVA followed by Fisher test). (D) Skin biopsies obtained on day 6 were stained with Masson’s trichrome. Images of
the center of wounds were captured using an inverted microscope (Magnification 100X). (E) Number of intradermal inflammatory infiltrates in the periphery of
wounds was quantified (n = 8).
combination with PRPr. In the same line of evidence, an in vitro
study has demonstrated that glucose alone (15–25 mM) failed to
induce cellular activation processes required for the infiltration
of neutrophils into inflamed tissue as chemotaxis and adhesion.
However, in combination with the chemoattractant stimulus
fMLP, both inflammatory cellular responses were synergistically
increased in the presence of glucose (Oldenborg and Sehlin,
1999). In addition, a previous work published by our group has
demonstrated that inhibition of in vitro angiogenic responses
(including endothelial proliferation, migration, survival and
tubule formation) induced by TNF-α is increased in combination
with glucose (Mena et al., 2018). These results suggest
that glucose synergizes with other stimuli to enhance pro-
inflammatory and anti-angiogenic responses. It is well known
that platelet alpha granules not only contain growth factors but
other molecules including cytokines and chemokines (e.g., SDF-
1α, IL-8, IL-17, TNF-α, RANTES, ENA-78, MCP-1) (Etulain et al.,
2012, 2018; Amable et al., 2013; Andia and Abate, 2013; Anitua
et al., 2019). Thus, it is conceivable that local cytokines derived
from platelets act in combination with glucose to induce the
recruitment of inflammatory cells into the dermis, and to inhibit
the angiogenesis required during wound healing and tissue
regeneration. It is also conceivable that local presence of high
glucose levels induces the activation and cytokine production
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from tissue and immune cells as it is traditionally known in the
context of diabetes (Donath et al., 2019). The requirement of
glucose in anticoagulants and preservative solutions have been
stablished to avoid lysis of erythrocytes during storage of these
cells for transfusion (Mollison, 2000). Considering that red cells
are not required for using PRP for regenerative purposes, the
addition of glucose could be avoided, and SC could be used as
anticoagulant instead of ACD.
Finally, and according with a recent publication about the
effect of diluting SC to increase fibroblast proliferation mediated
by PRPr (Anitua et al., 2016), we found that half reduction
of SC and ACD resulted in the improvement of endothelial
proliferation and migration mediated by PRPr. In contrast,
platelet-mediated regenerative responses were only improved by
reduction of SC but not ACD indicating that anti-regenerative
effect exerted by this anticoagulant is not prevented by dilution.
This phenomenon might be associated with the persistence of
inflammatory infiltrates in 1/2ACD-PRP impeding the resolution
of inflammation required during wound healing (Zhao et al.,
2016; Sorg et al., 2017). In agreement with our data, two recent
studies have showed that PRP obtained from anticoagulated
blood is better to induce proliferative and regenerative responses
mediated by platelets (Miron et al., 2017; Du et al., 2018). One of
these studies has demonstrated that mouse skin wound closure
is faster induced by PRPr prepared without anticoagulant than
ACD-PRPr (Du et al., 2018). Controversially, the development of
intradermal inflammatory papules after ACD-PRPr injection was
not mentioned in this study. Of note, it is unknown whether the
inflammatory phenomenon that we have observed using Balb/c
mice could be also developed in Nude mice that have an alteration
of immune system, not only in T-cells but also a defective
activation of granulocytes and monocytes (Wysoczynski et al.,
2017). Besides these discrepancies, we agree that using non-
coagulated blood is a physiological alternative to reduce
the harmful effect of anticoagulants. However, spontaneous
coagulation of blood obtained without anticoagulant constitutes
a limitation in handling times from blood extraction to
PRP application. Thus, reduction of anticoagulant could be
an alternative balance to reduce the anti-regenerative effect
of anticoagulants allowing convenient manipulation. Indeed,
and in agreement with Anitua findings (Anitua et al., 2016),
in preliminary settings we have observed that basal levels
of hemostatic functions of PRP (including aggregation and
coagulation) were similar and completely inactivated between
total and half concentration of anticoagulants-PRP. In agreement
again with Anitua (Anitua et al., 2016), activation responses
induced by stimulus addition (as PAR-1 activated peptide)
were similar induced in the presence of both concentrations
of anticoagulants, but they were reached 20–40% faster in
treatments containing half amount of SC or ACD (data not
shown). Thus, hemostatic proprieties of PRP are conserved in
treatments containing half amount of anticoagulants.
Extrapolation of our findings to the clinic might explain
the inflammatory reactions observed in patients after receiving
regenerative and local treatments with PRP (Bowman et al.,
2013; Kaux et al., 2014; Alam et al., 2018; Latalski et al., 2019).
These complications were not associated with the presence of
leukocytes in PRP since all the interventions were performed
using free-leukocyte PRP. Of note, all of these procedures were
performed using PRP anticoagulated with ACD and without
calcium restoration arguing about a possible toxic effect caused
by the anticoagulant. Unfortunately, and in contrast with the
industrialized medical drugs that require pharmacovigilance,
the heterogeneity of platelet-derived products hinders the
establishment of regulatory frameworks worldwide required to
apply a mandatory and unified record of side effects (Anitua
et al., 2015; Beitzel et al., 2015). To count with more of these
registers would allow a deeper understanding about the adverse
effects of anticoagulants used in regenerative protocols mediated
by platelets allowing providing therapeutic strategies to prevent
and treat these complications.
CONCLUSSION
Our findings demonstrate that reduction of calcium levels
exerted by citrate-anticoagulants interferes with the angiogenic
and regenerative proprieties of platelets. This effect is
reversed by restitution of calcium levels. D-Glucose (Dextrose)
contained in ACD confers anti-angiogenic, anti-regenerative
and inflammatory proprieties to PRP suggesting that, in
contrast with protocols for obtaining blood-derivatives for
transfusion, SC could be considered for obtaining platelets for
regeneration. Finally, blood obtained with half amount of SC
is the best alternative to improve the regenerative responses
mediated by PRP.
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